(4-Methyl-1,4-diazepan-1-yl)-[2-[[4-(3-propan-2-ylbenzotriazol-5-yl)-2-pyridinyl]amino]-4-pyridinyl]methanone

InChIKey	`GYGIXVNDVQQAPJ-UHFFFAOYSA-N`
Compound Name	(4-Methyl-1,4-diazepan-1-yl)-[2-[[4-(3-propan-2-ylbenzotriazol-5-yl)-2-pyridinyl]amino]-4-pyridinyl]methanone
Canonical SMILES	`CC(C)n1nnc2ccc(-c3ccnc(Nc4cc(C(=O)N5CCCN(C)CC5)ccn4)c3)cc21`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	7.53
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
O60563	CCNT1	Homo sapiens	Human	PF00134 PF21797	8.5	IC50	ChEMBL
P50750	CDK9	Homo sapiens	Human	PF00069	8.5	IC50	ChEMBL
Q00534	CDK6	Homo sapiens	Human	PF00069	6.7	IC50	ChEMBL
P06493	CDK1	Homo sapiens	Human	PF00069	6.4	IC50	ChEMBL